Ever since Braak and Braak demonstrated the neuropathological staging of Alzheimer’s disease (AD) with tau aggregates [1, 2], the noninvasive measurement of tau propagation has been of great clinical interest. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.